Guidelines on neutropenias
Guidelines by areas of disease
- Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines
- Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group
- Recommendations regarding splenectomy in hereditary hemolytic anemias
- Recommendations for Pregnancy in Rare Inherited Anemias
- The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper
- EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
- Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
- Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report
- ESC Guidelines on cardio-oncology
- Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults
- Antifungal prophylaxis in adult patients with acute myeloid leukemia treated with novel targeted therapies
- Human immunodeficiency virus-associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials
- Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
- Recommendations for diagnosis and treatment of methemoglobinemia
- The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children
- Management of Pregnancy in Rare Inherited Anemias
- Guidelines on neutropenias
- European guidelines on treatment and supportive measures in chronic neutropenias
- Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up